Impact of cardiovascular risk factors on the clinical presentation and survival of pulmonary embolism without identifiable risk factor

Background The nature of pulmonary embolism (PE) without identifiable risk factor (IRF) remains unclear. The objective of this study is to investigate the potential relationship between cardiovascular risk factors (CVRFs) and PE without IRF (unprovoked) and assess their role as markers of disease severity and prognosis. Methods A case-control study was performed of patients with PE admitted to our hospital [2010–2019]. Subjects with PE without IRF were included in the cohort of cases, whereas patients with PE with IRF were allocated to the control group. Variables of interest included age, active smoking, obesity, and diagnosis of arterial hypertension, dyslipidemia or diabetes mellitus. Results A total of 1,166 patients were included in the study, of whom 64.2% had PE without IRF. The risk for PE without IRF increased with age [odds ratio (OR): 2.68; 95% confidence interval (CI): 1.95–3.68], arterial hypertension (OR: 1.63; 95% CI: 1.27–2.07), and dyslipidemia (OR: 1.63; 95% CI: 1.24–2.15). The risk for PE without IRF was higher as the number of CVRF increased, being 3.99 (95% CI: 2.02–7.90) for subjects with ≥3 CVRF. The percentage of high-risk unprovoked PE increased significantly as the number of CVRF rose [0.6% for no CVRF; 23.8% for a CRF, P<0.001 (OR: 9.92; 95% CI: 2.82–34.9); 37.5% for two CRFs, P<0.001 (OR: 14.8; 95% CI: 4.25–51.85); and 38.1% for ≥3, P<0.001 (OR: 14.1; 95% CI: 4.06–49.4)]. No significant differences were observed in 1-month survival between cases and controls, whereas differences in 24-month survival reached significance. Conclusions A relationship was observed between CVRF and PE without IRF, as the risk for unprovoked PE increased with the number of CVRF. In addition, the number of CVRF was associated with PE without IRF severity, but not with prognosis.

[1]  M. Humbert,et al.  2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS) , 2019, European Respiratory Journal.

[2]  M. Movahed,et al.  Obesity is strongly and independently associated with a higher prevalence of pulmonary embolism. , 2019, Respiratory investigation.

[3]  T. Münzel,et al.  Impact of symptomatic atherosclerosis in patients with pulmonary embolism. , 2019, International journal of cardiology.

[4]  J. Gallacher,et al.  Cardiovascular Risk Factors Associated With Venous Thromboembolism , 2019, JAMA cardiology.

[5]  Thomas Kahan,et al.  2018 ESC/ESH Guidelines for the management of arterial hypertension. , 2018, European heart journal.

[6]  C. Auger,et al.  Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry. , 2018, International journal of cardiology.

[7]  P. Bossuyt,et al.  Screening for Occult Cancer in Patients With Unprovoked Venous Thromboembolism , 2017, Annals of Internal Medicine.

[8]  A. Ruano-Raviña,et al.  Factors Influencing Hospital Stay for Pulmonary Embolism. A Cohort Study. , 2017, Archivos de bronconeumologia.

[9]  Lina Badimon,et al.  Guía ESC/EAS 2016 sobre el tratamiento de las dislipemias , 2017 .

[10]  J. Manson,et al.  Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies. , 2017, Circulation.

[11]  B. Tamizifar,et al.  Comparing three clinical prediction rules for primarily predicting the 30-day mortality of patients with pulmonary embolism: The “Simplified Revised Geneva Score,” the “Original PESI,” and the “Simplified PESI” , 2016, Advanced biomedical research.

[12]  W. Ageno,et al.  Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH , 2016, Journal of thrombosis and haemostasis : JTH.

[13]  W. Ageno,et al.  Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation , 2014, Thrombosis and Haemostasis.

[14]  John A. Heit,et al.  The epidemiology of venous thromboembolism , 2003, Journal of Thrombosis and Thrombolysis.

[15]  D. Fitzmaurice,et al.  [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. , 2014, Kardiologia polska.

[16]  Jeroen J. Bax,et al.  ESC Guidelines on the diagnosis and management of acute pulmonary embolism , 2014 .

[17]  S. Suissa,et al.  Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. , 2013, The American journal of medicine.

[18]  D. Xavier,et al.  Low-dose aspirin for preventing recurrent venous thromboembolism. , 2012, The New England journal of medicine.

[19]  H. Kluin-Nelemans,et al.  Infections and inflammatory diseases as risk factors for venous thrombosis , 2012, Thrombosis and Haemostasis.

[20]  P. Scarabin,et al.  Risk assessment for recurrent venous thrombosis , 2011, The Lancet.

[21]  Lisa Moores,et al.  Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. , 2010, Archives of internal medicine.

[22]  G. Jensen,et al.  Risk Factors for Venous Thromboembolism: Results From the Copenhagen City Heart Study , 2010, Circulation.

[23]  P. Libby,et al.  Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. , 2008, The New England journal of medicine.

[24]  Cecilia Becattini,et al.  Cardiovascular Risk Factors and Venous Thromboembolism: A Meta-Analysis , 2008, Circulation.

[25]  S. Pocock,et al.  Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration , 2007, PLoS medicine.

[26]  R. Schmieder,et al.  Guidelines for management of arterial hypertension , 2007 .

[27]  M. Prins,et al.  Venous thromboembolism and the risk of subsequent symptomatic atherosclerosis , 2006, Journal of thrombosis and haemostasis : JTH.

[28]  W. Ageno,et al.  A prospective study on cardiovascular events after acute pulmonary embolism. , 2005, European heart journal.

[29]  J. Eriksson,et al.  The risk of venous thromboembolism is markedly elevated in patients with diabetes , 2005, Diabetologia.

[30]  B. Psaty,et al.  Serum Lipid Levels and the Risk of Venous Thrombosis , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[31]  T. Baglin,et al.  Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study , 2003, The Lancet.

[32]  T. Aitman,et al.  A novel role for CD36 in VLDL-enhanced platelet activation. , 2003, Diabetes.

[33]  M. Prins,et al.  An association between atherosclerosis and venous thrombosis. , 2003, The New England journal of medicine.

[34]  D. Corella,et al.  Hyperlipidaemia and venous thromboembolism in patients lacking thrombophilic risk factors , 2002, British journal of haematology.

[35]  E. Oger Incidence of Venous Thromboembolism: A Community-based Study in Western France , 2000, Thrombosis and Haemostasis.

[36]  W M O'Fallon,et al.  Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. , 2000, Archives of internal medicine.

[37]  Samuel Z Goldhaber,et al.  Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER) , 1999, The Lancet.

[38]  F. Rosendaal Venous thrombosis: a multicausal disease , 1999, The Lancet.

[39]  Jeffrey S. Ginsberg,et al.  The Role of Venous Ultrasonography in the Diagnosis of Suspected Deep Venous Thrombosis and Pulmonary Embolism , 1998, Annals of Internal Medicine.

[40]  J. Remy,et al.  Central pulmonary thromboembolism: diagnosis with spiral volumetric CT with the single-breath-hold technique--comparison with pulmonary angiography. , 1992, Radiology.

[41]  R. Deyo,et al.  Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. , 1992, Journal of clinical epidemiology.

[42]  P. Investigators,et al.  Value of the ventilation/perfusion scan in acute pulmonary embolism. Results of the prospective investigation of pulmonary embolism diagnosis (PIOPED). , 1990, JAMA.

[43]  C K Wells,et al.  Evaluation of clinical methods for rating dyspnea. , 1988, Chest.

[44]  J. Gore,et al.  Occult malignant neoplasm in patients with deep venous thrombosis. , 1987, Archives of internal medicine.